Work

A phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory metastatic colorectal cancer.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.4_suppl.450

Authors: Michael J. Overman, Cathy Eng, Bryan K. Kee, David R. Fogelman, Christine Fark, Rick Hippert, Scott Holter, Jean-Pierre Issa, Stanley R. Hamilton, Scott Kopetz

Institutions: The University of Texas MD Anderson Cancer Center, Temple University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590320093

Cites:

Cited by: 1

Related to: 10